Canada Gazette, Part I, Volume 151, Number 36: GOVERNMENT NOTICES
September 9, 2017
DEPARTMENT OF THE ENVIRONMENT
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Notice with respect to the Code of Practice for the Management of PM2.5 Emissions in the Potash Sector in Canada
Whereas on May 28, 2016, the Minister of the Environment issued the proposed Code of Practice for the Management of PM2.5 Emissions in the Potash Sector in Canada,
Pursuant to subsection 54(4) of the Canadian Environmental Protection Act, 1999, the Minister of the Environment hereby gives notice of the availability of the Code of Practice for the Management of PM2.5 Emissions in the Potash Sector in Canada issued under subsection 54(1) of that Act.
Electronic copies of this code of practice may be downloaded from the Internet at the following address: http://ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=A92426AA-1.
September 9, 2017
Marc D'Iorio
Director General
Industrial Sectors, Chemicals and Waste Directorate
On behalf of the Minister of the Environment
[36-1-o]
DEPARTMENT OF THE ENVIRONMENT
DEPARTMENT OF HEALTH
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Publication after screening assessment of three substances — hydrogen sulfide (H2S), CAS RN (see footnote 1) 7783-06-4; sodium sulfide [Na(SH)] (sodium bisulfide), CAS RN 16721-80-5; and sodium sulfide (Na2S), CAS RN 1313-82-2 — specified on the Domestic Substances List (subsection 77(1) of the Canadian Environmental Protection Act, 1999)
Whereas hydrogen sulfide (H2S), sodium bisulfide [Na(SH)], and sodium sulfide (Na2S) are substances identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999;
Whereas a summary of the draft screening assessment conducted on the substances pursuant to section 74 of the Act is annexed hereby;
And whereas it is proposed to conclude that the substances do not meet any of the criteria set out in section 64 of the Act,
Notice therefore is hereby given that the Minister of the Environment and the Minister of Health (the ministers) propose to take no further action on the substances at this time under section 77 of the Act.
Notice is further given that options are being considered for follow-up activities to track changes in exposure to hydrogen sulfide (H2S).
Public comment period
As specified under subsection 77(5) of the Canadian Environmental Protection Act, 1999, any person may, within 60 days after publication of this notice, file with the Minister of the Environment written comments on the measure the ministers propose to take and on the scientific considerations on the basis of which the measure is proposed. More information regarding the scientific considerations may be obtained from the Canada.ca (Chemical Substances) website (www.canada.ca/en/health-canada/services/chemical-substances.html). All comments must cite the Canada Gazette, Part I, and the date of publication of this notice and be sent to the Executive Director, Program Development and Engagement Division, Department of the Environment, Gatineau, Quebec K1A 0H3, by fax to 819-938-5212, or by email to eccc.substances.eccc@canada.ca.
In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this notice may submit with the information a request that it be treated as confidential.
Jacqueline Gonçalves
Director General
Science and Risk Assessment Directorate
On behalf of the Minister of the Environment
David Morin
Director General
Safe Environments Directorate
On behalf of the Minister of Health
ANNEX
Summary of the draft screening assessment of hydrogen sulfide, sodium bisulfide, and sodium sulfide
Pursuant to section 74 of the Canadian Environmental Protection Act, 1999 (CEPA), the Minister of the Environment and the Minister of Health have conducted a screening assessment of hydrogen sulfide (H2S) [Chemical Abstracts Service Registry Number (CAS RN) 7783-06-4], sodium sulfide [Na(SH)], referred to as sodium bisulfide in this assessment (CAS RN 16721-80-5), and sodium sulfide (Na2S) [CAS RN 1313-82-2]. These substances were identified as priorities for assessment, as they met categorization criteria under subsection 73(1) of CEPA.
Hydrogen sulfide is a naturally occurring inorganic gas produced from the anaerobic degradation of organic matter and is therefore widely present in anaerobic sediments and water and in biological wastes. It is also found naturally in crude oil petroleum, natural gas, volcanic gases and hot springs and is released from these natural sources primarily to air and to water under specific environmental conditions. It can also be released as a result of anthropogenic activities. Industrial operations that release hydrogen sulfide in Canada include those at oil and gas facilities, at kraft pulp and paper mills, and at wastewater treatment systems, as well as mining production and intensive livestock operations.
Sodium bisulfide is reported to be used in Canada as a chemical intermediate for commercial uses in dyes in textiles, paints and coatings, non-pesticidal agricultural products, and building and construction materials (wood and engineered wood). Sodium sulfide is used in Canada in pulp and paper processing, wastewater treatment, mining and smelting, and in food packaging not in direct contact with food. These two substances will dissociate to form bisulfide and sulfide anions and hydrogen sulfide if released to water. Considering that the likely medium of release for these substances is the air and aquatic environments, the environmental assessment is focused on hydrogen sulfide. Similarly, if exposure of the general Canadian population to undissociated sodium bisulfide or sodium sulfide were to occur, either salt would rapidly and completely hydrolyze in bodily fluids to result in the formation of hydrogen sulfide. No specific additional hazard is associated with either salt beyond that associated with hydrogen sulfide. The human health risk characterization is therefore focused on exposure to hydrogen sulfide.
According to an extensive database of measurements in Canada, hydrogen sulfide has been reported in air, surface water, and wastewater effluents in the vicinity of pulp and paper operations, oil and gas facilities, wastewater treatment systems, and livestock operations.
Hydrogen sulfide has the potential to harm both aquatic organisms and terrestrial plants when they are exposed at low concentrations. In the case of plants, however, low concentrations can also have stimulatory effects.
A risk quotient analysis determined that current hydrogen sulfide concentrations in Canadian air near anthropogenic sources are unlikely to be high enough to cause adverse effects to terrestrial wildlife (mammals or plants) and that concentrations in surface water near such sources are also unlikely to cause adverse effects to aquatic organisms.
Considering all available lines of evidence presented in this draft screening assessment, there is a low risk of harm to organisms or the broader integrity of the environment from these substances. It is therefore proposed to conclude that hydrogen sulfide, sodium bisulfide and sodium sulfide do not meet the criteria under paragraph 64(a) or (b) of CEPA, as they are not entering the environment in a quantity or concentration or under conditions that have an immediate or long-term harmful effect on the environment or its biological diversity or that constitute or may constitute a danger to the environment on which life depends.
Inhalation is expected to be the predominant route of exposure to hydrogen sulfide for the general population, and the health effects assessment focused on data examining effects of exposure by this route. No genotoxicity or carcinogenicity classifications by other national or international regulatory agencies were identified. The available information does not indicate that hydrogen sulfide is genotoxic or carcinogenic. The upper-bounding concentrations of hydrogen sulfide in ambient air are based on a review of the available Canadian monitoring data. The range of concentrations of 1–31 ppb (1.4–43.4 µg/m3) is used in the risk characterization. The lowest value of this range represents the overall average concentration measured in an urban area presumed to be away from major anthropogenic sources; the highest value of the range is the highest of all 99th percentile concentrations derived from measurements near point sources in Canada. Margins between upper-bounding concentrations of hydrogen sulfide in ambient air and levels associated with critical health effects (ocular, respiratory, neurological effects) are considered to be adequate to address uncertainties in the health effects and exposure databases. In occupational settings, severe health effects have been reported due to accidental acute exposure to high levels of hydrogen sulfide. These levels, specific to industrial settings, are several orders of magnitude higher than concentrations encountered in a community setting and are not considered relevant for risk characterization of the general population. Further, requirements are typically in place in occupational settings for the protection of workers, requirements that may include measures to prevent accidental releases of hydrogen sulfide and/or surveillance of air levels to ensure they are below occupational exposure limits. Available toxicity studies conducted specifically with sodium sulfide and sodium bisulfide are summarized in the health effects section.
Based on the information presented in this draft screening assessment, it is proposed to conclude that hydrogen sulfide, sodium bisulfide and sodium sulfide do not meet the criteria under paragraph 64(c) of CEPA, as they are not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health.
Proposed conclusion
It is proposed to conclude that hydrogen sulfide (H2S), sodium bisulfide [Na(SH)] and sodium sulfide (Na2S) do not meet any of the criteria set out in section 64 of CEPA.
Consideration for follow-up
While exposure of the general population to hydrogen sulfide (H2S) is not a concern at current levels, hydrogen sulfide (H2S) is associated with health effects of concern. Therefore, there may be a concern for human health if exposure of Canadians were to increase. Follow-up activities to track changes in exposure to hydrogen sulfide (H2S) are being considered and will include current monitoring initiatives at the federal and provincial/territorial levels.
Stakeholders are encouraged to provide, during the 60-day public comment period on the draft screening assessment, any information pertaining to the substance that may help inform the choice of follow-up activity. This could include information on new or planned import, manufacture or use of the substance, if the information has not previously been submitted to the ministers.
The draft screening assessment for these substances is available on the Canada.ca (Chemical Substances) website (www.canada.ca/en/health-canada/services/chemical-substances.html).
[36-1-o]
DEPARTMENT OF HEALTH
CONTROLLED DRUGS AND SUBSTANCES ACT
Notice to interested parties — Non-prescription availability of low-dose codeine products
This notice provides interested stakeholders with the opportunity to provide comments on the potential risks, benefits, and impacts of changes to the regulations to the Controlled Drugs and Substances Act that would require all products containing codeine to be sold by prescription only. Comments received by Health Canada will be considered in determining whether and how to proceed with this potential change.
Codeine is an opioid drug that is used to treat mild to moderate pain and cough. Opioids are a class of drugs with psychoactive properties and addiction potential. Due to the potential for addiction, most codeine products are available by prescription only; however, section 36 of the Narcotic Control Regulations exempts products containing low doses of codeine (8 mg or less per pill, or 20 mg or less per 30 mL of liquid medications) from the requirement to be sold by prescription, as long as certain conditions are met. These low-dose codeine products are currently available to consumers without a prescription in most of Canada, except in Manitoba, where more stringent requirements came into effect in February 2016.
In 2015, over 600 million low-dose codeine tablets were sold in Canada, the equivalent of 20 tablets for every person living in Canada that year. When low-dose codeine products are used improperly, individuals may be exposed to higher doses of codeine, leading to an increased risk of dependence or addiction. For example, in Ontario alone, from 2007 to 2015, an average of 880 individuals per year (representing approximately 2.0% of total admissions per year) who were newly admitted into publicly funded addiction treatment centres indicated non-prescription codeine products as one of their five problem substances. In that same nine-year period, over 500 individuals admitted to these treatment centres stated that non-prescription codeine was their only problem substance.
Evidence of problematic use of and dependence on non-prescription codeine products has also been documented in other countries where these preparations are available. Potential changes to Canada's regulations to require all codeine products to be sold by prescription would be in line with those already in place in many countries, including Belgium, Croatia, Czech Republic, Finland, France, Greece, Iceland, India, Italy, Norway, Russia and Sweden. Australia recently made changes that will place similar restrictions on low-dose codeine products as of February 2018. Currently in the United States, the availability of low-dose codeine products without a prescription varies from state to state.
While this potential change may mean patients will access the health care system for products that they may otherwise have accessed without the intervention of a prescriber, it will also create an avenue for Canadians to take all relevant factors into consideration (such as other health conditions or other medications) when talking to their health care providers about what medication is right for them. Some published studies suggest analgesics without codeine provide similar pain relief as low-dose codeine products. For example, a scientific review conducted in 2010 indicated that other commonly used analgesics (including non-steroid anti-inflammatory drugs that do not contain codeine or other opioids) provided more effective pain relief than 60 mg of codeine alone.
There is also concern that reducing the availability of low-dose codeine products may lead to a shift from codeine to other, potentially more dangerous drugs, and/or a shift among current users to sourcing opioids from illicit markets, rather than from health care professionals.
The publication of this notice in the Canada Gazette, Part I, initiates a 60-day comment period. Anyone interested in this process or who has comments on this notice should contact Legislative and Regulatory Affairs, Controlled Substances Directorate, Healthy Environments and Consumer Safety Branch, Health Canada, by mail at Address Locator: 0302A, 150 Tunney's Pasture Driveway, Ottawa, Ontario K1A 0K9, or by email at ocs_regulatorypolicy-bsc_politiquereglementaire@hc-sc.gc.ca.
Michelle Boudreau
Director General
Controlled Substances Directorate
[36-1-o]
DEPARTMENT OF HEALTH
HAZARDOUS MATERIALS INFORMATION REVIEW ACT
Filing of claims for exemption
Pursuant to paragraph 12(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer hereby gives notice of the filing of the claims for exemption listed below.
In accordance with subsection 12(2) of the Hazardous Materials Information Review Act, affected parties, as defined, may make written representations to the screening officer with respect to the claim for exemption and the safety data sheet (SDS) or label to which it relates. Written representations must cite the appropriate registry number, state the reasons and evidence upon which the representations are based and be delivered within 30 days of the date of the publication of this notice in the Canada Gazette, Part I, to the screening officer at the following address: Workplace Hazardous Materials Bureau, 269 Laurier Avenue West, 8th Floor, Ottawa, Ontario K1A 0K9.
Julie Calendino
Chief Screening Officer
On February 11, 2015, the Hazardous Products Act (HPA) was amended and the Controlled Products Regulations (CPR) and the Ingredient Disclosure List were repealed and replaced with the new Hazardous Products Regulations (HPR). The revised legislation (HPA/HPR) is referred to as WHMIS 2015 and the former legislation (HPA/CPR) is referred to as WHMIS 1988. Transitional provisions allow compliance with either the WHMIS 1988 or WHMIS 2015 for a specified period of time.
The claims listed below seek an exemption from the disclosure of supplier confidential business information in respect of a hazardous product; such disclosure would otherwise be required under the provisions of the relevant legislation.
| Claimant | Product Identifier | Subject of the Claim for Exemption | Registry Number |
|---|---|---|---|
| Halliburton Group Canada | SandWedge® NT | C.i. and C. of one ingredient C. of three ingredients | 11614 |
| Halliburton Group Canada | CL-38 CROSSLINKER | C.i. and C. of one ingredient C. of one ingredient | 11615 |
| Halliburton Group Canada | EXPEDITE 225 COMPONENT A |
C.i. and C. of one ingredient C. of one ingredient | 11616 |
| Halliburton Group Canada | Arctic SandWedge® | C.i. and C. of one ingredient C. of three ingredients | 11617 |
| Halliburton Group Canada | SandWedge® ABC | C.i. and C. of one ingredient C. of one ingredient | 11618 |
| Halliburton Group Canada | Cla-Web™ | C.i. and C. of one ingredient | 11619 |
| Halliburton Group Canada | FDP-M1066-12 | C.i. and C. of one ingredient C. of two ingredients | 11620 |
| Halliburton Group Canada | SCALECHEK LP-50 | C.i. and C. of one ingredient C. of two ingredients |
11621 |
| Halliburton Group Canada | SCALECHEK LP-70 | C.i. and C. of one ingredient C. of two ingredients | 11622 |
| Halliburton Group Canada | FDP-S1267-16 | C. of one ingredient | 11623 |
| Multi-Chem Production Chemicals Co. | MC MX 3-4458 | C.i. of two ingredients | 11624 |
| Secure Energy Services Inc. | SECURE THERMOSOLV 10C | C.i. and C. of two ingredients | 11625 |
| Secure Energy Services Inc. | SECURE THERMOSOLV 16C | C.i. and C. of two ingredients | 11626 |
| The Lubrizol Corporation | Lubrizol® 9684 | C.i. and C. of four ingredients | 11627 |
| 3M Canada Company | Scotchguard™ Spot Remover and Upholstery Cleaner | C. of two ingredients | 11628 |
| 3M Canada Company | 8001 Static Control Surface Mark Remover | C. of two ingredients | 11629 |
| 3M Canada Company | Sharpshooter™ Extra Strength No Rinse Mark Remover | C. of two ingredients | 11630 |
| 3M Canada Company | Sharpshooter™ Extra Strength No Rinse Mark Remover (Bulk Volumes) | C. of two ingredients | 11631 |
| 3M Canada Company | 3M™ Controltac™ Film Remover R221 | C. of four ingredients | 11632 |
| 3M Canada Company | 3M™ Stainless Steel Cleaner & Polish | C. of two ingredients | 11633 |
| 3M Canada Company | Super Clear Lens Cleaning Anti-Stat Fluid | C. of two ingredients | 11634 |
| 3M Canada Company | 3M™ Screen Printing Ink 1913 Red Shade Orange | C. of four ingredients | 11635 |
| 3M Canada Company | 3M™ 3-in-1 Floor Cleaner Concentrate (Product No. 24, 3M™ Chemical Management Systems) | C. of one ingredient | 11636 |
| Canadian Energy Services | STIMWRX-HA2 | C. of one ingredient | 11637 |
| 3M Canada Company | 3M™ Brand Super Trim Adhesive, PN 08090 | C. of three ingredients | 11638 |
| 3M Canada Company | 3M™ Self-Leveling Seam Sealer PN 08307 Part A (Accelerator) | C. of one ingredient | 11639 |
| 3M Canada Company | 3M™ Self-Leveling Seam Sealer PN 08307 Part B (Base) PN 08307 | C. of one ingredient | 11640 |
| 3M Canada Company | 3M™ Duramix™ Factory-Match Doorskin Sealer, 08323 Black (Part B) |
C. of one ingredient | 11641 |
| 3M Canada Company | 3M(TM) PLASTIC AND EMBLEM ADHESIVE-CLEAR P.N. 08061 | C. of one ingredient | 11642 |
| 3M Canada Company | 3M™ Heavy Drip-Chek™ Sealer, PN 08531 | C. of two ingredients | 11643 |
| 3M Canada Company | 3M™ Undercoating, PN 08881 |
C. of two ingredients | 11644 |
| 3M Canada Company | 3M™ Universal Adhesive Part B PN 08214 |
C. of one ingredient | 11645 |
| 3M Canada Company | 3M™ Panel Bonding (90 Minutes) Adhesive Part A (Accelerator) PN 08115 | C. of two ingredients | 11646 |
| 3M Canada Company | 3M(TM) High Power Brake Cleaner, P.N. 08880 | C. of four ingredients | 11647 |
| 3M Canada Company | 3M(TM) SILICONE LUBRICANT (DRY); PN 08897 | C. of five ingredients | 11648 |
| 3M Canada Company | 3M™ Panel Bonding Adhesive 08116 (Base) Part B | C. of two ingredients | 11649 |
| 3M Canada Company | 3M™ Silicone Lubricant Plus (Wet Type), 08877 | C. of two ingredients | 11650 |
| 3M Canada Company | 3M™ Polyester Resin PN 31110 | C. of one ingredient | 11651 |
| 3M Canada Company | 3M(TM) Urethane Seam Sealer, Beige, PN 08365 | C. of two ingredients | 11652 |
| 3M Canada Company | 3M(TM) Marine Fiberglass Restorer and Wax, PN 09005 | C. of one ingredient | 11653 |
| 3M Canada Company | 3M(TM) Marine Fiberglass Restorer and Wax, PN 09006 | C. of two ingredients | 11654 |
| 3M Canada Company | 3M™ Controlled-Flow Seam Sealer PN 08329 (Part B) | C. of two ingredients | 11655 |
| 3M Canada Company | 3M(TM) Machine Polish, PN 05996 | C. of one ingredient | 11656 |
| 3M Canada Company | 3M(TM) Panel Bonding Adhesive PN 58115 - Part A | C. of two ingredients | 11657 |
| 3M Canada Company | 3M™ Panel Bonding Adhesive Part B PN 58115 | C. of two ingredients | 11658 |
| 3M Canada Company | 3M™ Controlled-Flow Seam Sealer PN 08329 (Part A) | C. of two ingredients | 11659 |
| 3M Canada Company | 3M(TM) 3M Lightweight Body Filler PN 05800 | C. of two ingredients | 11660 |
| Baker Hughes Canada Company | PETROSWEET™ HSO3506 SCAVENGER | C.i. and C. of three ingredients C. of three ingredients | 11661 |
| 3M Canada Company | 3M™ Concrete Repair Horizontal Gray, Part A | C. of two ingredients | 11662 |
| 3M Canada Company | AP86A, Clear | C. of two ingredients | 11663 |
| 3M Canada Company | 3M™ Hi-Strength 94 ET Cylinder Spray Adhesive, Red | C. of two ingredients | 11664 |
| 3M Canada Company | 3M(TM) SCOTCH-WELD(TM) 3549 B/A PART B URETHANE ADHESIVE |
C. of two ingredients | 11665 |
| 3M Canada Company | 3M™ Scotch-Weld™ Urethane Adhesive DP640, Part B | C. of two ingredients | 11666 |
| 3M Canada Company | 3M™ Aerospace Sealant AC-350 A-2 Catalyst | C. of one ingredient | 11667 |
| 3M Canada Company | 3M™ Hi-Strength 94 CA Postforming Bulk Adhesive | C. of two ingredients | 11668 |
| 3M Canada Company | 3M™ Scotch-Weld™ Epoxy Adhesive EC-2615 B/A LW (Part B) | C. of one ingredient | 11669 |
| 3M Canada Company | 3M™ Scotch-Weld™ Epoxy Adhesive EC-2615 B/A LW, Part A | C. of two ingredients | 11670 |
| Secure Energy Services Inc. | SR3895-C | C.i. and C. of three ingredients | 11671 |
| Afton Chemical Corporation | C124040 | C.i. and C. of one ingredient C. of four ingredients | 11672 |
| Secure Energy Services Inc. | SECURE CSI-7509 | C.i. and C. of four ingredients C. of two ingredients | 11673 |
| Secure Energy Services Inc. | SECURE THERMOSOLV 20C | C.i. and C. of two ingredients | 11674 |
| Afton Chemical Corporation | HiTEC 65027T Fuel Additive | C.i. and C. of two ingredients | 11675 |
| Afton Chemical Corporation | Nemo 1129T | C.i. and C. of two ingredients | 11676 |
| 3M Canada Company | 3M(TM) Marine One Step Aluminum Restorer and Polish, PN 09020 | C. of one ingredient | 11677 |
| 3M Canada Company | 3M™ SMC/Fiberglass Adhesive - PN 08227 - PART B | C. of one ingredient | 11678 |
| 3M Canada Company | 3M™ Dynatron® Auto Seam Sealer White Caulk, PN 570 | C. of two ingredients | 11679 |
| 3M Canada Company | 3M™ Scotchguard™ Paint Protector PN 38600 | C. of one ingredient | 11680 |
| 3M Canada Company | 3M™ Reinforced Filler PN 05877 | C. of two ingredients | 11681 |
| 3M Canada Company | 3M™ Dynatron® MEKP Liquid Hardener 411 | C. of two ingredients | 11682 |
| 3M Canada Company | 3M™ Blue Cream Hardener for DMS | C. of two ingredients | 11683 |
| 3M Canada Company | 3M™ Red Cream Hardener PN 05830 | C. of two ingredients | 11684 |
| 3M Canada Company | 3M™ Urethane Seam Sealer, PN 08367, Black | C. of three ingredients | 11685 |
| 3M Canada Company | 3M Accessory Products, Air Tool Lubricant | C. of two ingredients | 11686 |
| 3M Canada Company | 3M™ Finesse-it™ Polish, K211 PN 28695 | C. of two ingredients | 11687 |
| 3M Canada Company | 3M™ Finesse-it™ Polish, K211 PN 28793 | C. of two ingredients | 11688 |
| 3M Canada Company | 3M™ Finesse-it™ Polish - Extra Fine, 6002 | C. of two ingredients | 11689 |
| 3M Canada Company | 3M™ Scotchcast™ Electrical Insulating Resin 4N, Part B | C.i. and C. of two ingredients C. of two ingredients | 11690 |
| 3M Canada Company | 3M™ Aerospace Sealant AC-250 B-1/6 Catalyst | C. of one ingredient | 11691 |
| 3M Canada Company | 3M™ Scotch-Weld™ Urethane Adhesive DP640, Part A | C. of four ingredients | 11692 |
| 3M Canada Company | 3M(TM) SCOTCH-WELD(TM) URETHANE ADHESIVE 604NS, BLACK (PART B) | C. of one ingredient | 11693 |
| 3M Canada Company | 3M™ Scotch-Weld™ Epoxy Adhesive EC-2216 B/A Gray, Part B | C. of one ingredient | 11694 |
| 3M Canada Company | 3M™ Scotch-Weld™ Epoxy Adhesive EC-2216 B/A Gray, Part A | C. of two ingredients | 11695 |
| 3M Canada Company | 3M(TM) SCOTCH-WELD(TM) URETHANE ADHESIVE EC-3549 BA PART A | C. of three ingredients | 11696 |
| 3M Canada Company | 3M(TM) SCOTCH-WELD(TM) STRUCTURAL ADHESIVE FILM AF 163-3 | C. of one ingredient | 11697 |
| 3M Canada Company | 3M™ Scotch-Weld™ Structural Adhesive Film AF 30 | C. of two ingredients | 11698 |
| 3M Canada Company | 3M(TM) Scotch-Weld(TM) Rubber and Gasket Adhesive EC-847 | C. of one ingredient | 11699 |
| 3M Canada Company | 3M(TM) Scotch-Weld(TM) Structural Adhesive Film AF 31 |
C. of one ingredient | 11700 |
| 3M Canada Company | 3M™ Scotch-Weld™ Structural Adhesive Primer EC-1290 (10% Solids) | C. of two ingredients | 11701 |
| 3M Canada Company | 3M(TM) Scotch-Weld(TM) Epoxy Structural Adhesive 9323 B/A (Part A) | C. of two ingredients | 11702 |
| 3M Canada Company | 3M™ Scotch-Weld™ Structural Adhesive EC-7236 B/A Black : Part A | C. of one ingredient | 11703 |
| 3M Canada Company | 3M™ Scotch-Weld™ Structural Adhesive EC-7236 B/A : Part A | C. of two ingredients | 11704 |
| 3M Canada Company | 3M™ Scotch-Weld™ Structural Adhesive 7246-2 B/A FST Part A | C. of one ingredient | 11705 |
| 3M Canada Company | 3M™ Dynamar™ Rubber Additive FX 5166 | C. of two ingredients | 11706 |
| 3M Canada Company | 3M(TM) Super 77(TM) Multipurpose Adhesive (Aerosol) | C. of four ingredients | 11707 |
| 3M Canada Company | 3M(TM) Scotch-Weld(TM) Neoprene High Performance Contact Adhesive 1357 | C. of four ingredients | 11708 |
| 3M Canada Company | 3M™ Scotch-Weld™ Instant Adhesive CA5 Clear | C. of one ingredient | 11709 |
| 3M Canada Company | 3M(TM) Scotch-Weld(TM) Structural Plastic Adhesive DP8005, Black, Part B | C. of three ingredients | 11710 |
| 3M Canada Company | 3M(TM) Scotch-Weld(TM) Threadlocker TL90, Green | C. of two ingredients | 11711 |
| 3M Canada Company | 3M(TM) 94 ET Hi Strength Aerosol Spray Adhesive Low VOC 20%, Clear | C. of two ingredients | 11712 |
| 3M Canada Company | 3M™ Scotch-Weld™ Urethane Adhesive DP605NS Off-White, Part A | C. of one ingredient | 11713 |
| 3M Canada Company | 3M(TM) Scotch-Weld(TM) Void Filling Compound EC-3524 B/A Off-White, Part A |
C. of two ingredients | 11714 |
| 3M Canada Company | 3M(TM) Scotch-Weld(TM) Void Filling Compound EC-3524 B/A Off-White, Part B |
C. of three ingredients | 11715 |
| 3M Canada Company | 3M(TM) SCOTCH-WELD(TM) EC-3524 B/A PART A VOID FILLING COMPOUND | C. of two ingredients | 11716 |
| 3M Canada Company | 3M(TM) SCOTCH-WELD(TM) CORE SPLICE ADHESIVE FILM AF-3024 | C. of four ingredients | 11717 |
| 3M Canada Company | 3M(TM) Scotch-Weld(TM) Epoxy Adhesive EC-3542 B/A FR Part B | C. of two ingredients | 11718 |
| 3M Canada Company | 3M™ Neoprene Contact Adhesive 5, Neutral Sprayable | C. of four ingredients | 11719 |
| 3M Canada Company | 3M™ Scotch-Weld™ Epoxy Adhesive 420 Off-White, Part B | C. of one ingredient | 11720 |
| 3M Canada Company | 3M(TM) HI-STRENGTH NON-FLAMMABLE 98NF BULK ADHESIVE, CLEAR | C. of one ingredient | 11721 |
| Secure Energy Services Inc. | SECURE THERMOSOLV NCC | C.i. and C. of one ingredient C. of three ingredients |
11722 |
| Nalco Canada ULC | EMBR18127A | C.i. and C. of one ingredient C. of five ingredients | 11723 |
| Ivey International Inc. | Ivey-sol 108 | C.i. and C. of five ingredients | 11724 |
| Allnex Canada Inc. (c/o Goodmans, LLP) |
EBECRYL® 81 radiation curing resins | C.i. of one ingredient | 11725 |
| Halliburton Group Canada | FightR EC-2 | C.i. and C. of two ingredients | 11726 |
| Halliburton Group Canada | TRANSCEND-425 | C.i. and C. of four ingredients C. of two ingredients | 11727 |
| Ingevity Corporation | Ultra Plas 1388 | C.i. and C. of three ingredients | 11728 |
| GE Water & Process Technologies Canada | Optyrex 602 | C.i. and C. of one ingredient | 11729 |
| Dorf Ketal Chemicals LLC | DA 2394 | C.i. of one ingredient C. of two ingredients |
11730 |
| BASF Canada Inc. | Basazol Brown 43 L NA | C.i. and C. of one ingredient C. of one ingredient | 11731 |
| BASF Canada Inc. | Pergasol Red 53 L NA | C.i. and C. of one ingredient | 11732 |
| Nalco Canada ULC | FHE4250W | C.i. of three ingredients C. of six ingredients | 11733 |
| Nalco Canada ULC | EMBR18198A | C.i. of one ingredient C. of eleven ingredients | 11734 |
| Sialco Materials Ltd, Delta | EBR-2432 | C.i. and C. of five ingredients | 11735 |
| Allnex Canada Inc. (c/o Goodmans, LLP) | EBECRYL® 3708 radiation curing resins | C.i. of one ingredient | 11736 |
| Allnex Canada Inc. (c/o Goodmans, LLP) | EBECRYL® 168 radiation curing resins | C.i. of one ingredient | 11737 |
Note: C.i. = chemical identity and C. = concentration
[36-1-o]
INNOVATION, SCIENCE AND ECONOMIC DEVELOPMENT CANADA
RADIOCOMMUNICATION ACT
Notice No. SMSE-011-17 — Consultation on New Requirements for Wireless Device Testing Laboratories
Notice is hereby given that Innovation, Science and Economic Development Canada (ISED) is releasing the following document:
The purpose of the consultation is to seek comments on proposed changes to the conformity assessment process related to wireless equipment subject to certification (Category I equipment).
The document listed above will be available as of the date of the publication of this notice.
Submitting comments
Interested parties are requested to submit their comments electronically (Microsoft Word or Adobe PDF) within 60 days of the date of publication of this notice using the following email address: ic.consultationradiostandards-consultationnormesradio.ic@canada.ca. In addition, respondents are asked to specify question numbers for ease of referencing.
All submissions should cite the Canada Gazette, Part I, the publication date, the title and the notice reference number (SMSE-011-17). Parties should submit their comments no later than 60 days following the date of publication of this document to ensure consideration. Soon after the close of the comment period, all comments received will be posted on ISED's Spectrum Management and Telecommunications Web site at http://www.ic.gc.ca/spectrum.
ISED will also provide interested parties with the opportunity to reply to comments from other parties. Reply comments will be accepted no later than 30 days following the date of publication of comments.
Following the initial comment period, ISED may, at its discretion, request additional information if needed to clarify significant positions or new proposals. In such a case, the reply comment deadline would be extended.
Obtaining copies
Copies of this notice and of the documents referred to herein are available electronically on the Spectrum Management and Telecommunications Web site at www.ic.gc.ca/spectrum.
Official versions of Canada Gazette notices can be viewed at www.gazette.gc.ca/rp-pr/p1/index-eng.html.
August 31, 2017
Martin Proulx
Director General
Engineering, Planning and Standards Branch
[36-1-o]
PRIVY COUNCIL OFFICE
Appointment opportunities
We know that our country is stronger — and our government more effective — when decision-makers reflect Canada's diversity. Moving forward, the Government of Canada will use an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous Canadians and minority groups are properly represented in positions of leadership. We will continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.
The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.
Current opportunities
The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council Appointments website (http://www.appointments-nominations.gc.ca/slctnPrcs.asp?menu=1&lang=eng).
| Position | Organization | Closing date |
|---|---|---|
| President and Chief Executive Officer | Atomic Energy of Canada Limited | September 29, 2017 |
| Chief Executive Officer | Canada Infrastructure Bank | September 14, 2017 |
| Chairperson | Canada Mortgage and Housing Corporation | September 11, 2017 |
| President | Canadian Institutes of Health Research | September 13, 2017 |
| Member | Copyright Board | September 13, 2017 |
| Vice-Chairperson | Copyright Board | September 13, 2017 |
| Member | Historic Sites and Monuments Board of Canada (N.B., N.W.T., B.C.) | September 20, 2017 |
| Members (appointment to roster) | International Trade International and Investment Dispute Settlement Bodies |
September 25, 2017 |
| Chairperson | Invest in Canada Hub | September 27, 2017 |
| Chief Executive Officer | Invest in Canada Hub | October 11, 2017 |
| Vice-Chairperson | Invest in Canada Hub | October 25, 2017 |
| Directors | Invest in Canada Hub | October 25, 2017 |
| Chairperson | National Battlefields Commission | September 12, 2017 |
| Commissioners | National Battlefields Commission | September 12, 2017 |
| Chief Executive Officer | National Museum of Science and Technology | September 25, 2017 |
| Commissioner of Lobbying | Office of the Commissioner of Lobbying | |
| Commissioner of Official Languages | Office of the Commissioner of Official Languages for Canada | |
| Conflict of Interest and Ethics Commissioner | Office of the Conflict of Interest and Ethics Commissioner | |
| Information Commissioner | Office of the Information Commissioner | |
| Senate Ethics Officer | Office of the Senate Ethics Officer | |
| Commissioner | Royal Canadian Mounted Police | September 15, 2017 |
| Administrator | Ship-source Oil Pollution Fund and Fund for Railway Accidents Involving Designated Goods | September 23, 2017 |
| Deputy Administrator | Ship-source Oil Pollution Fund and Fund for Railway Accidents Involving Designated Goods | September 23, 2017 |
Ongoing opportunities
| Position | Organization | Closing date |
|---|---|---|
| Full-time and Part-time Members | Immigration and Refugee Board | December 31, 2017 |
| Members | Veterans Review and Appeal Board | December 31, 2017 |
Upcoming opportunities
| Position | Organization |
|---|---|
| Director | Canada Post Corporation |
| Chairperson | Civilian Review and Complaints Commission for the Royal Canadian Mounted Police |
| Sergeant-at-Arms | House of Commons |
| Commissioner | International Joint Commission |
| Chief Electoral Officer | Office of the Chief Electoral Officer |
[36-1-o]